11-73660759-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021200.3(PLEKHB1):c.502G>A(p.Val168Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000259 in 1,592,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021200.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLEKHB1 | NM_021200.3 | c.502G>A | p.Val168Ile | missense_variant | 7/8 | ENST00000354190.10 | NP_067023.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLEKHB1 | ENST00000354190.10 | c.502G>A | p.Val168Ile | missense_variant | 7/8 | 1 | NM_021200.3 | ENSP00000346127.5 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000241 AC: 52AN: 215340Hom.: 0 AF XY: 0.000258 AC XY: 30AN XY: 116260
GnomAD4 exome AF: 0.000262 AC: 377AN: 1440180Hom.: 0 Cov.: 30 AF XY: 0.000249 AC XY: 178AN XY: 714346
GnomAD4 genome AF: 0.000236 AC: 36AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | The c.502G>A (p.V168I) alteration is located in exon 7 (coding exon 7) of the PLEKHB1 gene. This alteration results from a G to A substitution at nucleotide position 502, causing the valine (V) at amino acid position 168 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at